Tweet from AVXL #ClinicalData from #Alzheimers,
Post# of 1460
#ClinicalData from #Alzheimers, #Parkinsons and #Rettsyndrome strengthens the foundation of #ANAVEX®2-73 as a cross-platform #centralnervoussystem (#CNS) drug confirmed with a #precisionmedicine predictive biomarker response.
https://twitter.com/anavexlifesci/status/1410...68591?s=11